The Rising Interventional Pulmonology Market Driven by Increasing Incidence of Lung Cancer
Interventional pulmonology involves minimally invasive techniques to diagnose and treat various pulmonary diseases. Some common procedures include bronchoscopy, chest drainage, pleural biopsy, andLaser therapies. These procedures help in early diagnosis of conditions like lung cancer and emphysema. They are associated with reduced recovery time, less pain and scarring compared to open surgeries. The rising prevalence of lung cancer and other respiratory diseases has boosted the demand for such minimally invasive procedures in pulmonology.
The Global Interventional Pulmonology Market is estimated to be valued at US$ 3,535.3 Mn in 2021 and is expected to exhibit a CAGR of 5.4% over the forecast period 2021 to 2028.

Key Takeaways
Key players operating in the interventional pulmonology market are Boston Scientific Corporation, Olympus Corporation, FUJIFILM Corporation, Becton, Dickinson and Company, Smiths Group plc., Cook Medical, Vygon, PENTAX Medical, Clarus Medical LLC, HUGER Medical Instrument Co., Ltd., Richard Wolf Corporation, Karl Storz, Taewoong Medical Co., Ltd., and ELLA – CS, s.r.o.
Interventional Pulmonology Market Growth for lung cancer screening and diagnostic procedures is a major factor driving market growth. According to the American Cancer Society, lung cancer accounts for around 25% of all cancer deaths globally. This has increased the uptake of minimally invasive bronchoscopy and biopsy procedures for early detection.
Technological advancements are enabling higher accuracy and precision in interventional pulmonology procedures. Developers are focusing on advanced navigation systems, robotics and CAD/CAM software to guide instruments. This is improving clinical outcomes and expanding the applications of minimally invasive therapies.
Market Trends
The rising popularity of robotic-assisted bronchoscopy is a key trend in the market. Robotics provide enhanced dexterity, precision and 3D visualization over conventional bronchoscopes. This allows interventionists to reach smaller and harder-to-access lung segments for diagnostic and therapeutic procedures.
Another trend gaining ground is the increasing preference for single-use bronchoscopes to prevent infection transmission. Disposable bronchoscopes help reduce reprocessing costs and eliminate risks of defective cleaning or damage to reusable equipment. This drives their adoption in ambulatory surgical centers and office-based labs.
Market Opportunities
The growing geriatric population vulnerable to respiratory diseases creates opportunities for market players. Over 62% of new lung cancer patients are above 65 years of age presenting a target demographic.
Technological advances in electromagnetic navigation bronchoscopy also present lucrative opportunities. It uses CT images and proprietary software for real-time 3D tracking of endobronchial instruments. This allows intervention even in previously inaccessible lung areas increasing the overall market potential.
Impact of COVID-19 on Interventional Pulmonology Market Growth
The COVID-19 pandemic has significantly impacted the growth of the Interventional Pulmonology market. During the initial phases of the outbreak, non-essential procedures like interventional pulmonology were postponed to divert resources towards treating COVID-19 patients. This led to a decline in the demand for interventional pulmonology devices and consumables in 2020. However, as the pandemic progressed, telehealth and telemedicine saw increased adoption. This allowed pulmonologists to continue monitoring patients and conduct initial diagnostic assessments remotely. With vaccinations underway since 2021, the market has started recovering. While supply chain disruptions persist, demand is reviving as hospitals resume normal operations and non-urgent procedures. Post-COVID, the market is expected to regain momentum. However, future waves can negate growth again. To sustain, companies are focusing on R&D to develop technologies catering to new safety protocols and guidelines.
North America and Europe Account for Largest Share in Interventional Pulmonology Market
In terms of value, North America and Europe together hold the major share in the global Interventional Pulmonology market. This is attributed to factors such as the rising prevalence of respiratory diseases like lung cancer and presence of advanced healthcare facilities. The U.S. contributes significantly to North America's large market size owing to high healthcare spending and FDA approvals for new devices. European nations like Germany, France and the UK also account for sizeable revenue on the back of growing geriatric population suffering from chronic illnesses.
Asia Pacific Emerging as Fastest Growing Region for Interventional Pulmonology Market
The Asia Pacific region is poised to witness the fastest growth in the Interventional Pulmonology market during the forecast period. This is due to improving access to healthcare, increasing healthcare expenditures, growing public awareness about respiratory conditions and their treatments. Rapid urbanization and changing lifestyles leading to rising smoking rates in countries like China and India are fueling the incidence of lung diseases. Furthermore, growing medical tourism, availability of low-cost procedures and expanding network of private healthcare providers are aiding the APAC market expansion. Key players are also targeting this region through product launches, collaborations and manufacturing facilities to capitalize on its high growth potential.
Get more insights on, Interventional Pulmonology Market
Get This Report in Japanese Language: インターベンショナル呼吸器内科市場
Get This Report in Korean Language: 중재적 폐학 시장
About Author:
Vaagisha brings over three years of expertise as a content editor in the market research domain. Originally a creative writer, she discovered her passion for editing, combining her flair for writing with a meticulous eye for detail. Her ability to craft and refine compelling content makes her an invaluable asset in delivering polished and engaging write-ups.
(LinkedIn: https://www.linkedin.com/in/vaagisha-singh-8080b91)





